
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models
Author(s) -
Rocío GallegoDurán,
Leticia Álvarez-Amor,
Antonio GilGómez,
Ángela Rojas,
Rodrigo Muñoz,
Antonio Cádernas-García,
Douglas Maya-Miles,
Rocío MonteroVallejo,
Sheila Gato,
Yolanda Sánchez Torrijos,
Javier Ampuero,
Francisco Martín,
Manuel RomeroGómez
Publication year - 2019
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2019.6083/2018
Subject(s) - fatty liver , medicine , steatosis , steatohepatitis , endocrinology , pathophysiology , histology , choline , methionine , disease , biochemistry , biology , amino acid
non-alcoholic fatty liver disease is one of the most prevalent liver disorders in the developed world. Currently, there is no approved pharmacological therapy except for lifestyle intervention. Therefore, there is a need to increase the knowledge of preclinical models in order to boost novel discoveries that could lead to a better therapeutic management.